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ORIGINAL ARTICLE
Treatment of Striae Distensae with Nonablative 
Fractional Laser versus Ablative CO2 Fractional Laser: 
A Randomized Controlled Trial
You Jin Yang, M.D., Ga-Young Lee, M.D.
Department of Dermatology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea
Background: Striae distensae are atrophic dermal scars with 
overlying epidermal atrophy causing significant cosmetic 
concern. Although a variety of laser and light sources have 
been used for the treatment of striae distensae, to date no 
definite ‘gold standard’ treatment modality has been 
determined. Objective: To assess and compare the efficacy 
and safety of nonablative fractional photothermolysis and 
ablative CO2 fractional laser resurfacing in the treatment of 
striae distensae. Methods: Twenty-four ethnic South Korean 
patients with varying degrees of atrophic striae alba in the 
abdomen were enrolled in a randomized blind split study. 
The patients were treated with 1,550 nm fractional Er:Glass 
laser and ablative fractional CO2 laser resurfacing. Each half 
of the abdominal lesion was randomly selected and treated 
three times at intervals of 4-weeks using the same 
parameters. Digital photography was conducted and skin 
elasticity and the width of the widest striae in each subject 
were measured at the baseline and 4 weeks after the final 
treatment. Clinical improvement was assessed by comparing 
pre- and post-treatment clinical photographs by two blinded 
physicians and participant satisfaction rates were evaluated. 
Skin biopsies were taken from three participants. All adverse 
effects were reported during the study. Results: Although 
they do not statistically differ, both treatments with non-
ablative fractional laser and ablative CO2 fractional laser 
showed a significant clinical and histopathologic improve-
ment of striae distensae over pretreatment sites. Conclusion: 
These results support the use of nonablative fractional laser 
and ablative CO2  fractional laser as effective and safe 
treatment modalities for striae distensae of Asian skin. 
However, neither treatment showed any greater clinical 
improvement than the other treatment. (Ann Dermatol 23(4) 
481∼489, 2011)
-Keywords-
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INTRODUCTION
Striae distensae, or so called ‘stretch marks’, are atrophic 
linear dermal scars with overlying epidermal atrophy
1,2. 
They usually occur frequently in numerous physiological 
and pathological conditions such as adolescent growth 
spurts, pregnancy, obesity, Cushing’s and Marfan syndromes, 
and long-term systemic or topical steroid use
1. Especially 
in association with pregnancy, they are referred to as 
striae gravidarum. They have been noted to occur in more 
than 70% of pregnant women and are commonly found 
on the abdomen and breasts
2. Although they do not cause 
any significant medical problems, aesthetically they can 
be a cause of great concern or psychological stress for 
many women. There is much controversy over their patho-
physiology
1. Besides hereditary factors, corticosteroids and 
mechanical stretching of the skin are presumed contri-
butory factors in the development of striae distensae
1.YJ Yang and GY Lee
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A variety of treatment modalities have been attempted for 
striae distensae, but to date no definite ‘gold standard’ 
treatment modality has been determined. Topical therapy-
with tretinoin or glycolic acid have yielded variable 
results, although these treatments work poorly if at all on 
mature striae (striae alba)
3,4. Laser therapy has been 
advocated as a treatment option for striae distensae
5-19, 
including the following types: flash-pumped 585-nm pulse 
dye laser, intense pulsed light, 308-nm excimer laser, 
nonablative 1,450-nm diode laser, radiofrequency device, 
1,064-nm Nd:YAG laser, nonablative fractional photo-
thermolysis, and ablative fractional CO2 resurfacing. 
Recent studies have suggested that nonablative fractional 
photothermolysis and ablative fractional CO2 resurfacing 
are the two most promising laser modalities for striae 
distensae in Asian skin
15-19. However, a study comparing 
the clinical efficacy of the ablative vs. nonablative 
fractional photothermolysis system for the treatment of 
striae distensae has not been conducted.   
The purpose of our study was to evaluate and compare 
the clinical efficacy and safety of nonablative fractional 
laser (NAFL) and ablative CO2 fractional laser (CO2FL) 
methods in the treatment of striae distensae in Asian skin. 
MATERIALS AND METHODS
Subjects
Twenty-four ethnic South Korean female volunteers 
(Fitzpatrick skin types IV) aged between 30 and 48 with 
varying degrees of atrophic striae alba, developed on the 
abdomen after pregnancy, were enrolled in the study at 
the Department of Dermatology, Kangbuk Samsung Hos-
pital between September 2010 and June 2011. Exclusion 
criteria were the history of keloid scarring or connective 
tissue disease, vitamin A derivatives use within 2 months 
of study initiation, any treatment procedure for striae 
distensae including any type of laser modality within 1 
year of study initiation, pregnancy, use of immuno-
suppressive drugs, and any other diseases which can affect 
the wound-healing process. The protocol and informed 
consent were approved by the Kangbuk Samsung Hospital 
Institutional Review Board. This study was designed as a 
single-center, prospective, double-blind, randomized com-
parative split-scar trial.
Treatment protocol
Prior to laser procedure, a topical anesthetic cream (Encain
Ⓡ 
[mixture of lidocaine and prilocaine], Kolma Korea Co., 
Ltd, Seoul, Korea) was applied under an occlusive 
dressing for 60 minutes and subsequently washed off. The 
striae treatment areas were divided in half using the 
patients’ umbilicus as the midline on the abdomen. On a 
randomly selected half side of the abdomen skin lesion, 
the patients were treated with 1,550 nm fractional 
Er:Glass laser (Mosaic, Lutronic Co., Ltd, Seoul, Korea) at 
a pulse energy of 50 mJ and a spot density of 100 
spots/cm
2, using a scan area of 5×10 mm in a static mode 
with one pass administered per treatment site without 
overlapping. The other half side was treated with ablative 
fractional CO2 laser resurfacing (eCO2, Lutronic Co., Ltd, 
Seoul, Korea) at a pulse energy of 40∼50 mJ and a spot 
density of 75∼100 spots/cm
2, using a scan area of 8×8 
mm in a static mode. Because no definite laser parameters 
have been established for striae distensae, suitable 
parameters for the study were determined based on 
comparison of results of preliminary experiments using 
various parameters, such as high energy with low density 
or low energy with high density (data not shown). The 
patients received three laser treatments at 4-week intervals 
using the same parameters. 
Assessment
High resolution digital photographs were taken using 
identical camera settings (Canon, Tokyo, Japan) at the 
baseline and 4 weeks after the final treatment. The width 
of the widest striae in each subject was measured at the 
baseline and 4 weeks after the final treatment. Skin elasti-
city was determined with a non-invasive, in vivo suction 
skin elasticity meter (Aramo TS
TM, Aram Huvis Co., Ltd, 
Gyeonggi, Korea) using a 6-mm measuring probe. The 
difference of the width and skin elasticity was converted 
into the percentage of reduction from the baseline. Clinical 
improvement was evaluated by two blind-study physicians 
by comparing photographs. The criteria for evaluations 
using a quartile grading scale were as follows; 0=no 
improvement, 1=mild (percent improvement, <25%), 2 
=moderate (percent improvement, 26∼50%), 3=good 
(percent improvement, 51∼75%), 4=excellent (percent 
improvement, ＞76%). In addition, a patient satisfaction 
score was rated using the following scale; 0=not satisfied, 
1=slightly satisfied, 2=satisfied, 3=very satisfied, 4= 
extremely satisfied. 4-mm punch biopsy skin samples 
were taken from the most atrophic site before treatment 
and 4 weeks after the final laser treatment. The excised 
skin was fixed in 10% formalin and embedded in paraffin. 
Three micrometer-thick sections were stained with 
hematoxylin and eosin (H&E), Miller’s elastic stains, and 
Masson trichrome stains. Two dermatologists masked at 
the time of sampling evaluated the histopathologic results. 
The epidermal thicknesses of the biopsy specimens were 
measured using an optic micrometer. All adverse effects 
were checked during the study.Treatment of Striae Distensae with Nonablative Fractional Laser vs Ablative CO2 Fractional Laser
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Table 1. Baseline patient characteristics and clinical outcomes after laser treatment
Patient
number Age Duration
(years)
Improvement
grade (fractional)
Patient satisfaction 
grade (fractional)
Improvement grade 
(CO2 fractional)
Patient satisfaction 
grade (CO2 
fractional)
13 41 3 2 3 2 4
24 41 8 1 1 2 2
33 1 5 2 2 2 2
43 3 5 0 2 0 2
53 91 0 3 3 3 3
63 81 2 1 1 1 1
74 41 5 2 2 3 3
83 81 0 2 2 4 4
93 2 9 3 3 3 3
10 33 6 1 1 1 1
11 43 12 0 3 3 3
12 30 10 1 2 4 4
13 30 4 1 2 3 3
14 34 5 1 3 3 3
15 42 11 1 2 3 3
16 43 10 1 3 3 3
17 41 13 1 2 3 3
18 44 19 1 2 2 2
19 42 15 2 3 2 2
20 36 8 1 3 2 2
21 48 23 1 1 2 2
22 46 18 2 2 2 2
Table 2. Skin measuring apparatus assessment of skin elasticity and the width of the widest striae (Mean±SD)
Elasticity
(fractional)
Width
(fractional)
Elasticity
(CO2 fractional)
Width 
(CO2 fractional)
Baseline  59.05±8.81  7.00±2.20 56.32±8.83 6.77±2.62
After 3 sessions of laser treatment  69.55±9.49  4.55±1.60  68.23±9.38 4.43±1.94
% change from baseline       19.1±16.4%      32.4±19.9%      23.0±19.5%    29.7±27.4%
p-value <0.001 <0.001 <0.001 <0.001
SD: standard deviation.
Statistical analysis
All statistical analyses were carried out using IBM SPSS 
Statistics 19.0 (IBM, Armonk, New York, USA). The 
difference of skin elasticity and the width of the widest 
striae after laser treatment were analyzed by the repeated 
measures ANOVA test. The significances of the changes in 
skin elasticity and the width of the widest striae among the 
different laser modalities were determined using a paired 
t-test. The difference of clinical improvement and patient 
satisfaction score among the different laser modalities was 
analyzed by Pearson Chi-square and Fisher’s exact test. 
Data were expressed as mean±standard deviation and 
statistical significance was accepted for p-values less than 
0.05.
RESULTS
Of the 24 subjects initially enrolled, 22 completed the 
study. Two patients (8.3%) were excluded during treatment 
due to the occurrence of post-procedure pruritus and 
hyperpigmentation. The patients ranged in age from 30 to 
48 years (mean 38.4 years). The cause of striae distense 
was pregnancy in all participants. No patient had a 
previous treatment history of striae distensae. The mean 
duration of the striae distensae was 11.4 years (range 5∼
23 years). Table 1 details the subject characteristics.
Skin elasticity and the width of the widest striae  
On an average, pre- and post-treatment skin elasticity 
varied from 59.05 to 69.55 and the width of the widest 
striae decreased from 7.00 to 4.55 in NAFL-treated sites (p
＜0.001). In CO2FL-treated sites, the average value of skin 
elasticity increased from 56.32 to 68.23 and the width of YJ Yang and GY Lee
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Table 3. Clinical improvement in the appearance of the striae
Clinical improvement
Fractional 
No. pts (%)
CO2 
fractional 
No. pts (%)
Excellent improvement   0 (0) 0 (0)
 (4, 76∼100%)
Good improvement (3, 51∼75%)   2 (9.1) 3 (13.6)
Fair improvement (2, 26∼50%)   6 (27.3) 9 (40.9)
Poor improvement (1, 0∼25%) 12 (54.5) 8 (36.4)
No change (0, 0%)   2 (9.1) 2 (9.1)
Fig. 1. Patient 5. Improvement in 
clinical appearance of striae distensae.
Pre-treatment (A) and post-treatment
(B) with a nonablative fractional 
laser treatment. Baseline (C) and 
post-treatment (D) with a CO2
fractional laser treatment. 
the widest striae was markedly reduced from 6.77 to 4.43 
(p＜0.001). These two objective parameters showed statis-
tically significant differences between pre- and post- 
treatment states of both NAFL and CO2FL (p<0.001) 
(Table 2). To compare the therapeutic effects of the two 
laser modalities, we calculated the difference of skin 
elasticity and the width of the widest striae as percent 
value. In terms of skin elasticity, the CO2FL-treated sites 
(23.0±19.5) showed better improvement than the NAFL- 
treated sites (19.1±16.4) (p=0.377). The width of the 
widest striae was reduced more in the NAFL-treated sites 
(32.4±19.9) than in the CO2FL-treated sites (29.7±27.4) 
(p=0.486). However, there was no statistically significant 
difference between the two laser modalities.
Clinical improvement in the appearance of the striae  
In global photographs, 20 (90.9%) of the 22 patients were 
improved in the NAFL-treated sites. Among the 22 
patients, 2 (9.1%) were good, 6 (27.3%) were fair, and 12 
(54.5%) were poorly improved; however, 2 (9.1%) did not 
show any improvement after the treatment. Also, in 
CO2FL-treated sites, 20 (90.9%) of the 22 patients showed 
clinical improvement. Of the 22, 3 (13.6%) were good, 9 
(40.9%) were fair, and 8 (36.4%) were poorly improved; 
however, 2 (9.1%) did not show any improvement after 
the treatment (Table 3). Considering all the patients who 
were assessed with excellent, good, and fair improvement, 
12 patients (54.5%) in the CO2FL-treated sites demonstrated 
overall clinical improvement, which is greater than the 8 
patients (36.4%) in the NAFL-treated sites. However, the 
difference between the two laser modalities was not 
statistically significant (p=0.226) (Fig. 1, 2). 
Patient satisfaction rating
Using the self-administered questionnaire, 18 (81.8%) 
patients judged their condition as improved and 4 (18.2%) 
as stabilized in the NAFL-treated sites. In the CO2FL- 
treated sites, 20 (90.9%) patients judged their condition as 
improved and 2 (9.1%) as stabilized. None of the patients 
considered their condition worsened (Table 4). Patient 
satisfaction surveys paralleled the clinical improvements. 
Considering all the rating scales of patients with excellent, 
good, and fair improvement, patients were more satisfied 
with CO2FL than with NAFL. However, the difference 
between the two laser modalities did not show statistical 
significance (p=0.664).Treatment of Striae Distensae with Nonablative Fractional Laser vs Ablative CO2 Fractional Laser
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Fig. 2. Patient 8. Improvement in 
clinical appearance of striae distensae.
Pre-treatment (A) and post-treatment
(B) with a nonablative fractional laser
treatment. Baseline (C) and post-
treatment (D) with a CO2 fractional 
laser treatment. 
Table 4. Patients’ satisfaction score
Grade of 
satisfaction
Fractional
No. pts (%)
CO2 fractional
No. pts (%)
Excellent improvement (4)  0 (0) 3 (13.6)
Good improvement (3)  8 (36.4) 9 (40.9)
Fair improvement (2) 10 (45.4) 8 (36.4)
No change (1)  4 (18.2) 2 (9.1)
Aggravation (0)  0 (0) 0 (0)
Histological analysis
Pretreatment epidermal atrophy with flattening of the rete 
ridges and marked decrease of dermal collagen and elastic 
fibers were observed in all the cases. In the NAFL-treated 
sites, the average epidermal thickness was increased from 
66.3 to 73.3 μm and the amount of collagen and elastic 
fibers were markedly increased after the laser treatment 
(Fig. 3). In the CO2FL-treated sites, the epidermal thickness 
was also increased on an average from 61.7 to 87.6 μm 
and the amount of collagen and elastic fibers were 
increased, compared to the pre-treatment state (Fig. 4).
Side effects
The treatment was generally well tolerated. There was no 
significant long-lasting adverse effect except transient mild 
erythema and pigmentation. To evaluate the intensity of 
pain during the laser treatment, patients scored from 0 (no 
pain) to 10 (extremely intolerable pain). CO2FL treatment 
(average 6.41) was considered more painful than fractional 
laser treatment (average 3.41). Postinflammatory hyper-
pigmentation was noted in 8 patients (36.4%) in the 
NAFL-treated sites, and in 18 patients (81.8%) in the 
CO2FL-treated sites. Crusts remained longer in the CO2FL- 
treated sites (average 12 days) than in the NAFL-treated 
sites (average 3.5 days). Post-treatment erythema was 
noted for 6.43 days on an average after the CO2FL treat-
ment, which was longer than that for the NAFL treatment 
(5.09 days). There was no incidence of hypopigmentation, 
blistering, ulceration, or worsening of striae distensae with 
either device.
DISCUSSION
Successful treatment of striae distensae has always been 
challenging. Although several treatment modalities have 
been proposed, no consistent modality is available. Besides 
the traditional topical therapies such as tretinoin, hydrant 
creams, glycolic acids and trichloroacetic acids, lasers 
have recently become a popular therapeutic alternative in 
the treatment of striae distensae
5-19.
Fractional photothermolysis is a recently introduced laser 
treatment that creates numerous microscopic thermal 
injury zones of controlled width, depth, and density that 
are surrounded by a reservoir of spared epidermal and 
dermal tissue allowing for rapid repair of laser-induced 
thermal injury
16. Considering that fractional photothermolysis 
showed effectiveness in the treatment of atrophic scars, 
few reports have described the use of fractional photo-
thermolysis on the treatment of striae distensae
15-17. Bak et 
al.
17 revealed that a marked improvement of atrophic scar YJ Yang and GY Lee
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Fig. 3. Patient 13. Skin biopsies of untreated abdominal striae distensae (A, C, E) and the same site 1 month after three times of 
treatment with nonablative fractional laser (B, D, F), Note the increases in the epidermal thickness and the amount of collagen and 
elastic fibers after laser treatment. (A, B) H&E, ×200, (C, D) Masson trichrome stain, ×200, (E, F) Miller’s elastic stain, ×200.
was owing to the increase of epidermal and dermal 
thickness and regeneration of dermal collagen after the 
fractional laser treatment. The U.S. Food and Drug Admini-
stration has recently approved the nonablative 1,540-nm 
erbium-droped glass fractional photothermolysis system 
(Lux 1540, Palomar Medical Technologies, Inc., Burlington, 
MA) for use in striae distensae.
Although a CO2 laser could theoretically stimulate 
fibroblast activity and improve the lesions through delicate 
abrasion of the skin, it was recommended that people 
with skin types IV to VI should avoid CO2 laser treatments 
for striae distensae in concern for the development of 
postinflammatory dyschromia after ablative laser therapy, 
especially for lesions in locations other than the face
7. By 
incorporation of fractional technology into the conven-
tional ablative CO2 lasers, more desirable clinical results 
could be expected. The efficacy of an ablative fractional 
laser system for the treatment of striae distensae has been 
demonstrated in recent retrospective and prospective 
studies
18,19.   
Our result showed that both NAFL and CO2 FL improve 
the clinical appearance of striae distensae remarkably over Treatment of Striae Distensae with Nonablative Fractional Laser vs Ablative CO2 Fractional Laser
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Fig. 4. Patient 13. Skin biopsies of untreated abdominal striae distensae (A, C, E) and the same site 1 month after three times of
treatment with CO2 fractional laser (B, D, F), Note the increases in epidermal thickness and the amount of collagen and elastic fibers 
after the laser treatment. (A, B) H&E, ×200, (C, D) Masson trichrome stain, (E, F) ×200, Miller’s elastic stain, ×200.
pretreatment states. Global assessment by physicians and 
scoring by participants showed better improvement in the 
CO2 FL-treated sites than in the NAFL-treated sites, but the 
difference was not statistically significant. To evaluate the 
efficiency of laser treatment objectively, we used a non- 
invasive, in vivo suction skin elasticity meter and mea-
sured the width of the widest striae. In both of the NAFL 
and CO2FL-treated sites, the changes of mean skin 
elasticity and mean width of the widest striae were 
statistically significant. Although the CO2FL-treated sites 
showed better improvement in skin elasticity and NAFL 
induced more reduction of the width of the widest striae, 
there was no statistically significant difference between 
the two devices. Previous clinical studies demonstrated 
that NAFL and CO2FL increase the amount of melanin 
pigment and transform the whitish bands into a natural 
skin color in striae alba
15,18. Also in our study, almost all 
the striae alba bands showed marked changes of color. 
Along with the skin elasticity and textural changes, a more 
natural skin color tone created the marked clinical 
improvement. However, the small number of subjects 
(each group, n=3) might be a reason for the lack of YJ Yang and GY Lee
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difference between the two treatments. 
This study, to our knowledge, is the first study comparing 
the clinical efficacy of the ablative vs nonablative 
fractional photothermolysis systems for the treatment of 
striae distensae. CO2 laser resurfacing may induce more 
dermal extracellular matrix remodeling than the non-
ablative laser treatment
20,21, and CO2FL has been revealed 
to provide immediate tissue tightening and induce more 
collagen stimulation than nonablative fractional laser
22. 
For these reasons, we assume that CO2FL might promise 
better clinical improvement of striae distensae. Although 
both physicians and patients evaluated that CO2FL induced 
a better clinical improvement, we failed to prove the 
statistically significant difference between the two devices. 
The risk of post-treatment hyperpigmentation of striae 
distensae in darker skinned patients is a major concern to 
dermatologists. Also, because of the poor wound healing, 
caution is required when treating the abdomen, buttock, 
or legs which are the preferential sites of stria distensa. In 
our study, the side effects of both treatments were limited 
to transient erythema, crust formation, and mild hyper-
pigmentation. Most of the hyperpigmentation improved 
spontaneously within 4 weeks. Although patients treated 
with CO2FL reported greater pain, a high incidence of 
hyperpigmentation and longer duration of post-treatment 
erythema and crust, this perception of greater pain and 
greater side effects did not appear to correlate with the 
laser preference and satisfaction levels. Even though there 
was no statistical difference, both the objective global 
assessment and the subjective patient satisfaction showed 
better clinical improvement with CO2FL than with NAFL. 
Further studies might be needed to establish the optimal 
parameter and treatment interval to enhance treatment 
efficacy, minimize the adverse events and to determine 
the better laser treatment modalities for striae distensae, 
especially in Asian skin. The smaller spot size and shorter 
dwelling time of ablative and NAFL treatment might 
minimize the side effects by deeper penetration depth and 
less thermal diffusion into the surrounding tissue
23. 
In conclusion, we suggest that both NAFL and CO2FL may 
be effective and safe treatment options for striae distensae 
of Asian skin, although it is difficult to distinguish which 
of the two laser modalities might be superior. 
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